Cytek Biosciences, Inc. (CTKB) DCF Valuation

Cytek Biosciences, Inc. (CTKB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Cytek Biosciences, Inc. (CTKB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Cytek Biosciences, Inc. (CTKB) valuation with this customizable DCF Calculator! Featuring real Cytek Biosciences, Inc. (CTKB) financials and adjustable forecast inputs, you can test scenarios and uncover Cytek Biosciences, Inc. (CTKB) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 57.9 92.8 128.0 164.0 193.0 262.5 357.1 485.7 660.7 898.7
Revenue Growth, % 0 60.39 37.82 28.2 17.67 36.02 36.02 36.02 36.02 36.02
EBITDA -16.0 15.4 10.4 9.5 -4.4 .3 .4 .6 .8 1.1
EBITDA, % -27.61 16.55 8.13 5.81 -2.28 0.11866 0.11866 0.11866 0.11866 0.11866
Depreciation .3 .6 1.2 5.7 9.2 5.5 7.4 10.1 13.8 18.7
Depreciation, % 0.53384 0.64951 0.97069 3.48 4.78 2.08 2.08 2.08 2.08 2.08
EBIT -16.3 14.8 9.2 3.8 -13.6 -5.2 -7.0 -9.5 -13.0 -17.6
EBIT, % -28.15 15.9 7.16 2.34 -7.07 -1.96 -1.96 -1.96 -1.96 -1.96
Total Cash 30.1 165.2 364.6 341.1 262.4 237.4 322.9 439.1 597.3 812.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 17.7 18.1 29.8 48.9 56.1
Account Receivables, % 30.66 19.5 23.26 29.79 29.08
Inventories 18.4 23.0 32.2 48.2 60.9 74.9 101.9 138.6 188.5 256.4
Inventories, % 31.85 24.79 25.14 29.36 31.54 28.54 28.54 28.54 28.54 28.54
Accounts Payable 2.3 2.9 3.0 4.8 3.0 7.4 10.1 13.7 18.6 25.3
Accounts Payable, % 4.05 3.17 2.37 2.93 1.57 2.82 2.82 2.82 2.82 2.82
Capital Expenditure -1.0 -1.5 -4.4 -9.9 -4.8 -8.0 -10.9 -14.8 -20.2 -27.5
Capital Expenditure, % -1.68 -1.67 -3.41 -6.02 -2.5 -3.05 -3.05 -3.05 -3.05 -3.05
Tax Rate, % 22.67 22.67 22.67 22.67 22.67 22.67 22.67 22.67 22.67 22.67
EBITAT -16.8 19.9 6.8 7.8 -10.5 -4.7 -6.3 -8.6 -11.7 -15.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -51.3 14.6 -17.0 -29.6 -27.9 -30.2 -59.1 -80.5 -109.4 -148.8
WACC, % 10.75 10.75 10.69 10.75 10.7 10.73 10.73 10.73 10.73 10.73
PV UFCF
SUM PV UFCF -297.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -152
Terminal Value -1,740
Present Terminal Value -1,045
Enterprise Value -1,342
Net Debt -153
Equity Value -1,189
Diluted Shares Outstanding, MM 135
Equity Value Per Share -8.79

What You Will Get

  • Real CTKB Financial Data: Pre-filled with Cytek Biosciences’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Cytek Biosciences’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive CTKB Data: Pre-loaded with Cytek Biosciences' historical financials and future projections.
  • Customizable Parameters: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
  • Interactive Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • User-Centric Interface: Intuitive, organized, and tailored for both experienced professionals and newcomers.

How It Works

  • Download: Obtain the comprehensive Excel file containing Cytek Biosciences' financial data.
  • Customize: Tailor projections, including revenue growth, EBITDA %, and WACC to your preferences.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make changes.
  • Test Scenarios: Develop various forecasts and instantly evaluate different outcomes.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose Cytek Biosciences, Inc. (CTKB)?

  • Innovative Technology: Cutting-edge solutions for advanced cellular analysis.
  • Enhanced Accuracy: State-of-the-art instruments provide reliable data for your research.
  • Customizable Solutions: Adapt our products to meet your specific scientific needs.
  • User-Friendly Interface: Intuitive software ensures seamless operation and data interpretation.
  • Backed by Expertise: Supported by a team of professionals dedicated to your success.

Who Should Use Cytek Biosciences, Inc. (CTKB)?

  • Investors: Gain insights and make informed decisions with advanced bioscience analytics.
  • Research Scientists: Utilize cutting-edge tools for accurate data analysis in your experiments.
  • Healthcare Consultants: Tailor presentations and reports quickly with our user-friendly templates.
  • Biotechnology Enthusiasts: Enhance your knowledge of bioscience applications through practical examples.
  • Educators and Students: Leverage our resources as a hands-on learning aid in life sciences courses.

What the Template Contains

  • Preloaded CTKB Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.